Rifabutin-d7 structure
|
Common Name | Rifabutin-d7 | ||
|---|---|---|---|---|
| CAS Number | 1129491-38-8 | Molecular Weight | 240.21 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H6D2F2N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Rifabutin-d7Rufinamide-d2 (CGP 33101-d2) is the deuterium labeled Rufinamide. Rufinamide (E 2080) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS). |
| Name | Rifabutin-d7 |
|---|
| Description | Rufinamide-d2 (CGP 33101-d2) is the deuterium labeled Rufinamide. Rufinamide (E 2080) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS). |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C10H6D2F2N4O |
|---|---|
| Molecular Weight | 240.21 |